Checkmate Pharmaceuticals Funding: $85M Raised, Series C
Checkmate Pharmaceuticals is based in Cambridge, MA. It has raised $85M in total funding. Latest round: Series C.
Checkmate Pharmaceuticals funding overview
Checkmate Pharmaceuticals is based in Cambridge, MA. Checkmate Pharmaceuticals has raised $85M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series C announced in June 2020. The round record for Checkmate Pharmaceuticals runs through 2020; nothing later has been disclosed. Investors on record include Longitude Capital, Novo Holdings, Medixci, Omega Funds, Clough Capital Partners, Sectoral Asset Management and 5 others. 11 distinct backers are named across the disclosed rounds.
Checkmate Pharmaceuticals at a glance
Total raised
$85M
Latest round
Series C
Latest round date
June 2020
Headquarters
Cambridge, MA
Notable investors
Longitude Capital, Novo Holdings, Medixci, Omega Funds, Clough Capital Partners, Sectoral Asset Management, BrightEdge, Sofinnova Investments
Frequently asked about Checkmate Pharmaceuticals funding
How much has Checkmate Pharmaceuticals raised?
Checkmate Pharmaceuticals has raised $85M in total disclosed funding across the rounds on record.
Who has invested in Checkmate Pharmaceuticals?
Longitude Capital, Novo Holdings, Medixci, Omega Funds, Clough Capital Partners, Sectoral Asset Management are named among the investors backing Checkmate Pharmaceuticals.
What was the latest Checkmate Pharmaceuticals funding round?
The most recent disclosed round is a Series C, announced in June 2020.
Where is Checkmate Pharmaceuticals based?
Checkmate Pharmaceuticals is based in Cambridge, MA.
When did Checkmate Pharmaceuticals last raise?
The last disclosed Checkmate Pharmaceuticals round closed in June 2020 at Series C.
Checkmate Pharmaceuticals totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies in Cambridge below to benchmark round size and investor mix.
Companies related to Checkmate Pharmaceuticals (36)
